Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 219,966 | 13,969 | 34,021 | 36,619 | 48,036 |
| TOTAL | $220,379 | $15,215 | $35,300 | $37,999 | $49,033 |
| Non-Current Assets | |||||
| PPE Net | 31 | 52 | 68 | 101 | 17 |
| Other Non-Current Assets | 140 | 112 | 188 | 113 | 27 |
| TOTAL | $171 | $164 | $256 | $214 | $43 |
| Total Assets | $220,550 | $15,379 | $35,556 | $38,213 | $49,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,943 | 3,687 | 3,436 | 4,081 | 1,892 |
| Accrued Expenses | 10,949 | 3,843 | 2,680 | 2,820 | 740 |
| Other current liabilities | N/A | N/A | 2,791 | N/A | N/A |
| TOTAL | $24,495 | $10,822 | $12,175 | $7,171 | $2,632 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,333 | 3,619 | 6,663 | 9,470 | N/A |
| TOTAL | $17,333 | $3,619 | $6,663 | $9,470 | $N/A |
| Total Liabilities | $41,827 | $14,441 | $18,838 | $16,641 | $2,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,075 | 33,280 | 25,493 | 19,196 | N/A |
| Common Shares | 4 | 3 | 3 | 2 | 2 |
| Retained earnings | -175,896 | -107,550 | -76,585 | -47,642 | -20,440 |
| TOTAL | $178,722 | $938 | $16,717 | $21,572 | $46,444 |
| Total Liabilities And Equity | $220,550 | $15,379 | $35,556 | $38,213 | $49,076 |